IMMUTEP Ltd SEC filings IMMP
IMMUTEP Ltd has 739 filings in SEC EDGAR's recent list, going back to Feb 13, 2012. Its latest annual report, Form 20-F, was filed on Oct 23, 2026 for the period ended Jun 30, 2026. The most recent current report (Form 6-K) was filed on Nov 2, 2026. The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | May 11, 2026 | — |
| CORRESP | Letter to the SEC | Apr 24, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2026 | — |
| EFFECT | Filing | May 5, 2023 | — |
| CORRESP | Letter to the SEC | May 3, 2023 | — |
| UPLOAD | Letter from the SEC | May 2, 2023 | — |
| EFFECT | Filing | Oct 30, 2019 | — |
| CORRESP | Letter to the SEC | Oct 28, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 22, 2019 | — |
| D | Filing | Jul 30, 2019 | — |
| EFFECT | Filing | Feb 12, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 8, 2019 | — |
| CORRESP | Letter to the SEC | Feb 8, 2019 | — |
| D | Filing | Dec 21, 2018 | — |
| CT ORDER | Filing | Nov 16, 2018 | — |
| EFFECT | Filing | Nov 2, 2017 | — |
| CORRESP | Letter to the SEC | Oct 31, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 27, 2017 | — |
| D | Filing | Jul 14, 2017 | — |
| CT ORDER | Filing | Jan 24, 2017 | — |
| EFFECT | Filing | Jun 17, 2016 | — |
| CORRESP | Letter to the SEC | Jun 15, 2016 | — |
| UPLOAD | Letter from the SEC | Jun 14, 2016 | — |
| CT ORDER | Filing | Jan 5, 2016 | — |
| RW | Filing | Nov 18, 2014 | — |
| CT ORDER | Filing | Nov 6, 2014 | — |
| CT ORDER | Filing | Dec 18, 2012 | — |
| EFFECT | Filing | Apr 12, 2012 | — |
| CT ORDER | Filing | Apr 12, 2012 | — |
| CERTNAS | Auto-generated paper document | Apr 12, 2012 | — |
| 20FR12B/A | Amendment no. 3 to registration statement on form 20-f | Apr 12, 2012 | — |
| CORRESP | Letter to the SEC | Apr 11, 2012 | — |
| 20FR12B/A | Amendment no. 2 to registration statement on form 20-f | Apr 2, 2012 | — |
| UPLOAD | Letter from the SEC | Mar 21, 2012 | — |
| 20FR12B/A | Amendment no. 1 to registration statement on form 20-f | Mar 15, 2012 | — |
| UPLOAD | Letter from the SEC | Mar 1, 2012 | — |
| 20FR12B | Registration statement on form 20-f | Feb 13, 2012 | — |
Showing 37 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IMMP (Nasdaq), PRRUF (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- Australia
- Headquarters
- Sydney,, Australia
- SEC filer status
- Accelerated filer
- SEC CIK
- 1506184
- Former names
- Prima BioMed Ltd (until Dec 1, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.